Gaorong Capital logo

Gaorong Capital

Asia, Beijing, China, Wangjing

Description

Gaorong Capital, established in 2014 by industry veterans Zhang Zhen, Gao Xiang, and Li Haifeng, stands as a prominent venture capital firm headquartered in Wangjing, China. The firm has rapidly grown to become a significant player in the Chinese investment landscape, primarily focusing on early and growth stage opportunities. Its investment mandate broadly covers the TMT (Technology, Media, and Telecommunications) sector, with a particular emphasis on emerging areas such as artificial intelligence, frontier technologies, enterprise services, and consumer-related innovations.

Gaorong Capital employs a strategy centered on identifying and nurturing high-potential companies that are poised for significant disruption and growth within their respective markets. The firm is known for its hands-on approach, providing not just capital but also strategic guidance and operational support to its portfolio companies. This comprehensive support system aims to accelerate the development of startups from their nascent stages through to market leadership. Their investment philosophy often involves backing visionary founders with strong execution capabilities, aiming for long-term value creation.

Since its inception, Gaorong Capital has demonstrated substantial scale and impact. The firm manages over $3 billion in assets under management across multiple funds, reflecting its robust fundraising capabilities and investor confidence. This capital has enabled Gaorong to make over 200 investments in a diverse range of companies, many of which have gone on to achieve significant valuations and market presence. For instance, in 2021, the firm successfully closed its fifth USD-denominated fund at $850 million, further solidifying its capacity to deploy substantial capital into promising ventures. Their portfolio includes several unicorns and publicly listed companies, underscoring their track record of identifying and supporting successful enterprises across various economic cycles.

Investor Profile

Gaorong Capital has backed more than 66 startups, with 12 new investments in the last 12 months alone. The firm has led 13 rounds, about 20% of its total and boasts 22 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, Singapore.
  • Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Software.
  • Led 1 rounds in the past year.
  • Typical check size: $2M – $50M.

Stage Focus

  • Series B (30%)
  • Series A (27%)
  • Series C (20%)
  • Seed (9%)
  • Series Unknown (8%)
  • Series D (5%)
  • Angel (2%)

Country Focus

  • China (70%)
  • United States (14%)
  • Singapore (8%)
  • Ireland (3%)
  • United Kingdom (2%)
  • Nigeria (2%)
  • Australia (2%)
  • Hong Kong (2%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Software
  • Medical
  • Information Technology
  • Health Care
  • Financial Services
  • Internet
  • Real Estate
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gaorong Capital frequently co-invest with?

Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 5
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 7
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 5
Vision Plus Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 4
GSR Ventures
North America, California, United States, Menlo Park
Co-Investments: 10
Capital Today
Asia, Shanghai, China, Shanghai
Co-Investments: 4
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 7
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 11
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 4
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 8

Which angels does Gaorong Capital often collaborate with?

Xiaoguang Wu
Asia, Guangdong, China, Shenzhen
Shared Deals: 1
YM
North America, California, United States, Los Altos Hills
Shared Deals: 1
KA
North America, California, United States, San Francisco
Shared Deals: 1
FE
North America, California, United States, San Francisco
Shared Deals: 1
BK
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Gaorong Capital?

Tongxin Medical Equipment

Suzhou, Jiangsu, China

Tongxin Medical Equipment is an artificial-heart maker company.

Biotechnology
Series UnknownJul 21, 2025
Amount Raised: $100,000,000
Flexiv

Santa Clara, California, United States

Flexiv Ltd. is a global leading general-purpose robotics company, focusing on developing and manufacturing adaptive robots.

Artificial Intelligence (AI)Robotics
Series CJun 23, 2025
Amount Raised: $100,000,000
Pulnovo Medical

Wuxi, Anhui, China

Pulnovo Medical is a medical device company, specializing in the treatment of pulmonary artery hypertension.

Health CareMedicalMedical Device
Series CMar 3, 2025
Amount Raised: $100,000,000
HashKey

Hong Kong, Hong Kong Island, Hong Kong

HashKey Group is end-to-end digital asset financial services group.

Financial Services
Series UnknownFeb 14, 2025
Amount Raised: $30,000,000
Bivision

Shanghai, Shanghai, China

Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).

BiopharmaBiotechnologyHealth Diagnostics
Series AJan 17, 2025
Amount Raised: $13,515,358
Xinyanyi Code

Shenzhen, Guangdong, China

Xinyanyi Code is an artificial intelligence programming application service provider.

Series AJan 10, 2025
Ideaflow

Shenzhen, Guangdong, China

Ideaflow is an AGI-era content technology firm focused on developing a new generation of content platforms.

Artificial Intelligence (AI)
Series ADec 12, 2024
Allink Biotherapeutics

Shanghai, Shanghai, China

Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

BiopharmaBiotechnology
Series ANov 28, 2024
Amount Raised: $42,000,000
Zhongke Hydroyi

Ningbo, Zhejiang, China

Zhongke Hydroyi focuses on the research and development of polymer diaphragm products.

Information Technology
SeedNov 19, 2024
Amount Raised: $6,906,936
Vision Travel Technology

Chaoyang, Liaoning, China

Vision Travel Technology is an AI travel solution provider.

Artificial Intelligence (AI)TourismTravel
Series AOct 30, 2024
Amount Raised: $14,053,234